001     154461
005     20240229123102.0
024 7 _ |a 10.1002/ijc.33004
|2 doi
024 7 _ |a pmid:32270874
|2 pmid
024 7 _ |a 0020-7136
|2 ISSN
024 7 _ |a 1097-0215
|2 ISSN
024 7 _ |a altmetric:79475114
|2 altmetric
037 _ _ |a DKFZ-2020-00783
041 _ _ |a eng
082 _ _ |a 610
100 1 _ |a Campa, Daniele
|0 0000-0003-3220-9944
|b 0
245 _ _ |a Genome-wide association study identifies an early onset pancreatic cancer risk locus.
260 _ _ |a Bognor Regis
|c 2020
|b Wiley-Liss
336 7 _ |a article
|2 DRIVER
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|b journal
|m journal
|0 PUB:(DE-HGF)16
|s 1608046398_16491
|2 PUB:(DE-HGF)
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a Journal Article
|0 0
|2 EndNote
500 _ _ |a 2020 Oct 15;147(8):2065-2074#LA:C055#
520 _ _ |a Early onset pancreatic cancer (EOPC) is a rare disease with a very high mortality rate. Almost nothing is known on the genetic susceptibility of EOPC, therefore we performed a genome-wide association study (GWAS) to identify novel genetic variants specific for patients diagnosed with pancreatic ductal adenocarcinoma (PDAC) at younger ages. In the first phase, conducted on 821 cases with age of onset ≤60 years, of whom 198 with age of onset ≤50, and 3227 controls from PanScan I-II, we observed four SNPs (rs7155613, rs2328991, rs4891017 and rs12610094) showing an association with EOPC risk (P < 1x10-4 ). We replicated these SNPs in the PANcreatic Disease ReseArch (PANDoRA) consortium and used additional in silico data from PanScan III and PanC4. Among these four variants rs2328991 was significant in an independent set of 855 cases with age of onset ≤60 years, of whom 265 with age of onset≤50, and 4142 controls from the PANDoRA consortium while in the in silico data we observed no statistically significant association. However, the resulting meta-analysis supported the association (P = 1.15x10-4 ). In conclusion we propose a novel variant rs2328991 to be involved in EOPC risk. Even though it was not possible to find a mechanistic link between the variant and the function, the association is supported by a solid statistical significance obtained in the largest study on EOPC genetics present so far in the literature. This article is protected by copyright. All rights reserved.
536 _ _ |a 313 - Cancer risk factors and prevention (POF3-313)
|0 G:(DE-HGF)POF3-313
|c POF3-313
|f POF III
|x 0
588 _ _ |a Dataset connected to CrossRef, PubMed,
700 1 _ |a Gentiluomo, Manuel
|b 1
700 1 _ |a Obazee, Ofure Mary Ann
|0 P:(DE-He78)ac7a26c496af814293aa74ab92d5f5b3
|b 2
700 1 _ |a Ballerini, Alba
|b 3
700 1 _ |a Vodickova, Ludmila
|b 4
700 1 _ |a Hegyi, Péter
|b 5
700 1 _ |a Soucek, Pavel
|0 0000-0002-4294-6799
|b 6
700 1 _ |a Brenner, Hermann
|0 P:(DE-He78)90d5535ff896e70eed81f4a4f6f22ae2
|b 7
|u dkfz
700 1 _ |a Milanetto, Anna Caterina
|b 8
700 1 _ |a Landi, Stefano
|b 9
700 1 _ |a Gao, Xin
|b 10
700 1 _ |a Bozzato, Dania
|b 11
700 1 _ |a Capurso, Gabriele
|b 12
700 1 _ |a Tavano, Francesca
|0 0000-0002-8831-7349
|b 13
700 1 _ |a Vashist, Yogesh
|b 14
700 1 _ |a Hackert, Thilo
|b 15
700 1 _ |a Bambi, Franco
|b 16
700 1 _ |a Bursi, Simona
|b 17
700 1 _ |a Oliverius, Martin
|b 18
700 1 _ |a Gioffreda, Domenica
|b 19
700 1 _ |a Schöttker, Ben
|0 P:(DE-He78)c67a12496b8aac150c0eef888d808d46
|b 20
|u dkfz
700 1 _ |a Ivanauskas, Audrius
|b 21
700 1 _ |a Mohelnikova-Duchonova, Beatrice
|b 22
700 1 _ |a Darvasi, Erika
|b 23
700 1 _ |a Pezzilli, Raffaele
|b 24
700 1 _ |a Małecka-Panas, Ewa
|b 25
700 1 _ |a Strobel, Oliver
|b 26
700 1 _ |a Gazouli, Maria
|0 0000-0002-3295-6811
|b 27
700 1 _ |a Katzke, Verena
|0 P:(DE-He78)fb68a9386399d72d84f7f34cfc6048b4
|b 28
|u dkfz
700 1 _ |a Szentesi, Andrea
|b 29
700 1 _ |a Cavestro, Giulia Martina
|b 30
700 1 _ |a Farkas, Gyula
|b 31
700 1 _ |a Izbicki, Jakob R
|b 32
700 1 _ |a Moz, Stefania
|b 33
700 1 _ |a Archibugi, Livia
|b 34
700 1 _ |a Hlavac, Viktor
|b 35
700 1 _ |a Vincze, Áron
|b 36
700 1 _ |a Talar-Wojnarowska, Renata
|b 37
700 1 _ |a Rusev, Borislav
|b 38
700 1 _ |a Kupcinskas, Juozas
|b 39
700 1 _ |a Greenhalf, Bill
|b 40
700 1 _ |a Dijk, Frederike
|b 41
700 1 _ |a Giese, Nathalia
|b 42
700 1 _ |a Boggi, Ugo
|b 43
700 1 _ |a Andriulli, Angelo
|b 44
700 1 _ |a Busch, Olivier R
|b 45
700 1 _ |a Vanella, Giuseppe
|b 46
700 1 _ |a Vodicka, Pavel
|b 47
700 1 _ |a Nentwich, Michael
|b 48
700 1 _ |a Lawlor, Rita T
|b 49
700 1 _ |a Theodoropoulos, George E
|b 50
700 1 _ |a Jamroziak, Krzysztof
|b 51
700 1 _ |a Zuppardo, Raffaella Alessia
|b 52
700 1 _ |a Moletta, Lucia
|b 53
700 1 _ |a Ginocchi, Laura
|b 54
700 1 _ |a Kaaks, Rudolf
|0 P:(DE-He78)4b2dc91c9d1ac33a1c0e0777d0c1697a
|b 55
|u dkfz
700 1 _ |a Neoptolemos, John P
|b 56
700 1 _ |a Lucchesi, Maurizio
|b 57
700 1 _ |a Canzian, Federico
|0 P:(DE-He78)5323704270b6393dcea70186ffd86bca
|b 58
|e Last author
|u dkfz
773 _ _ |a 10.1002/ijc.33004
|0 PERI:(DE-600)1474822-8
|n 8
|p 2065-2074
|t International journal of cancer
|v 147
|y 2020
|x 0020-7136
909 C O |p VDB
|o oai:inrepo02.dkfz.de:154461
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 2
|6 P:(DE-He78)ac7a26c496af814293aa74ab92d5f5b3
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 7
|6 P:(DE-He78)90d5535ff896e70eed81f4a4f6f22ae2
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 20
|6 P:(DE-He78)c67a12496b8aac150c0eef888d808d46
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 28
|6 P:(DE-He78)fb68a9386399d72d84f7f34cfc6048b4
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 55
|6 P:(DE-He78)4b2dc91c9d1ac33a1c0e0777d0c1697a
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 58
|6 P:(DE-He78)5323704270b6393dcea70186ffd86bca
913 1 _ |a DE-HGF
|b Gesundheit
|l Krebsforschung
|1 G:(DE-HGF)POF3-310
|0 G:(DE-HGF)POF3-313
|3 G:(DE-HGF)POF3
|2 G:(DE-HGF)POF3-300
|4 G:(DE-HGF)POF
|v Cancer risk factors and prevention
|x 0
914 1 _ |y 2020
915 _ _ |a Nationallizenz
|0 StatID:(DE-HGF)0420
|2 StatID
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0200
|2 StatID
|b SCOPUS
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0300
|2 StatID
|b Medline
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0310
|2 StatID
|b NCBI Molecular Biology Database
915 _ _ |a JCR
|0 StatID:(DE-HGF)0100
|2 StatID
|b INT J CANCER : 2017
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0199
|2 StatID
|b Clarivate Analytics Master Journal List
915 _ _ |a WoS
|0 StatID:(DE-HGF)0110
|2 StatID
|b Science Citation Index
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0150
|2 StatID
|b Web of Science Core Collection
915 _ _ |a WoS
|0 StatID:(DE-HGF)0111
|2 StatID
|b Science Citation Index Expanded
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1030
|2 StatID
|b Current Contents - Life Sciences
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1050
|2 StatID
|b BIOSIS Previews
915 _ _ |a IF >= 5
|0 StatID:(DE-HGF)9905
|2 StatID
|b INT J CANCER : 2017
920 2 _ |0 I:(DE-He78)C055-20160331
|k C055
|l C055 Genomische Epidemiologie
|x 0
920 1 _ |0 I:(DE-He78)C055-20160331
|k C055
|l C055 Genomische Epidemiologie
|x 0
920 1 _ |0 I:(DE-He78)C070-20160331
|k C070
|l C070 Klinische Epidemiologie und Alternf.
|x 1
920 1 _ |0 I:(DE-He78)C120-20160331
|k C120
|l Präventive Onkologie
|x 2
920 1 _ |0 I:(DE-He78)HD01-20160331
|k HD01
|l DKTK HD zentral
|x 3
920 1 _ |0 I:(DE-He78)C020-20160331
|k C020
|l C020 Epidemiologie von Krebs
|x 4
980 _ _ |a journal
980 _ _ |a VDB
980 _ _ |a I:(DE-He78)C055-20160331
980 _ _ |a I:(DE-He78)C070-20160331
980 _ _ |a I:(DE-He78)C120-20160331
980 _ _ |a I:(DE-He78)HD01-20160331
980 _ _ |a I:(DE-He78)C020-20160331
980 _ _ |a UNRESTRICTED


LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21